Search results for " TRANSPLANT"

showing 10 items of 1575 documents

CD52‐negative T cells predict acute graft‐versus‐host disease after an alemtuzumab‐based conditioning regimen

2020

Allogeneic haematopoietic stem cell transplantation (HSCT) after a reduced-intensity conditioning (RIC) regimen with fludarabine, melphalan and alemtuzmab is an effective therapy for haematological malignancies. Alemtuzumab, a monoclonal antibody against CD52, a glycosylphosphatidylinositol-anchor-bound surface protein on lymphocytes, depletes T cells to prevent graft-versus-host disease (GVHD). Despite this, acute and chronic GVHD (a/cGVHD) remain life-threatening complications after HSCT. The aim of the present study was to identify parameters to predict GVHD. In 69 patients after HSCT, T-cell subsets were functionally analysed. Reconstitution of CD52neg T cells and CD52neg regulatory T c…

AdultMaleMelphalanReceptors CXCR3Transplantation ConditioningReceptors CCR5CD52Graft vs Host Diseasechemical and pharmacologic phenomenaCXCR3T-Lymphocytes Regulatory03 medical and health sciences0302 clinical medicineRisk Factorsimmune system diseaseshemic and lymphatic diseasesmedicineHumansAlemtuzumabAgedbusiness.industryHematopoietic Stem Cell TransplantationMembrane ProteinsHematologyMiddle AgedAllograftsFludarabineTransplantationHaematopoiesissurgical procedures operativeCD52 Antigen030220 oncology & carcinogenesisAcute DiseaseImmunologyAlemtuzumabFemaleStem cellbusiness030215 immunologymedicine.drugBritish Journal of Haematology
researchProduct

Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection an…

2008

ABSTRACT The performance of a plasma real-time PCR (cytomegalovirus [CMV] PCR kit; Abbott Diagnostics) was compared with that of the antigenemia assay for the surveillance of active CMV infection in 42 allogeneic hematopoietic stem cell transplantation (Allo-SCT) recipients. A total of 1,156 samples were analyzed by the two assays. Concordance between the two assays was 82.2%. Plasma DNA levels correlated with the number of pp65-positive cells, particularly prior to the initiation of preemptive therapy. Fifty-seven episodes of active CMV infection were detected in 37 patients: 18 were defined solely by the PCR assay and four were defined on the basis of the antigenemia assay. Either a cutof…

AdultMaleMicrobiology (medical)Adolescentmedicine.medical_treatmentCongenital cytomegalovirus infectionCytomegalovirusHematopoietic stem cell transplantationmedicine.disease_causeAntiviral AgentsChemopreventionPolymerase Chain ReactionSensitivity and SpecificityHerpesviridaelaw.inventionViral Matrix ProteinsPlasmalawBetaherpesvirinaeVirologymedicineHumansAntigens ViralPolymerase chain reactionAgedbiologyHematopoietic Stem Cell Transplantationvirus diseasesMiddle AgedViral LoadPhosphoproteinsmedicine.diseasebiology.organism_classificationVirologyReal-time polymerase chain reactionROC CurveCytomegalovirus InfectionsDNA ViralImmunologyFemaleViral diseaseViral loadJournal of Clinical Microbiology
researchProduct

Comparative Evaluation of Three Automated Systems for DNA Extraction in Conjunction with Three Commercially Available Real-Time PCR Assays for Quanti…

2011

ABSTRACT Limited data are available on the performance of different automated extraction platforms and commercially available quantitative real-time PCR (QRT-PCR) methods for the quantitation of cytomegalovirus (CMV) DNA in plasma. We compared the performance characteristics of the Abbott mSample preparation system DNA kit on the m24 SP instrument (Abbott), the High Pure viral nucleic acid kit on the COBAS AmpliPrep system (Roche), and the EZ1 Virus 2.0 kit on the BioRobot EZ1 extraction platform (Qiagen) coupled with the Abbott CMV PCR kit, the LightCycler CMV Quant kit (Roche), and the Q-CMV complete kit (Nanogen), for both plasma specimens from allogeneic stem cell transplant (Allo-SCT) …

AdultMaleMicrobiology (medical)BiologyReal-Time Polymerase Chain Reactionmedicine.disease_causeVirusAutomationchemistry.chemical_compoundVirologymedicineHumansTransplantation HomologousViremiaAgedTransplantationCytomegalovirusMiddle AgedViral LoadDNA extractionVirologyMolecular biologyTransplantationReal-time polymerase chain reactionchemistryCytomegalovirus InfectionsDNA ViralFemaleStem cellViral loadDNAStem Cell Transplantation
researchProduct

Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation

2009

BACKGROUND: Invasive pneumococcal disease is a life-threatening complication after allogeneic stem cell transplantation, and at least 20% of cases occur within 1 year after transplantation. The 23-valent pneumococcal polysaccharide vaccine (PPV23) has limited efficacy, especially during the first year after transplantation. The immune response to the conjugated vaccines is expected to be better than that to the polysaccharide vaccine, but the optimal timing of vaccination is not defined. Our objective was to show that a 7-valent pneumococcal conjugate vaccine (PCV7; Prevnar) was not inferior when first given 3 months after transplantation, compared with when first given 9 months after trans…

AdultMaleMicrobiology (medical)Pediatricsmedicine.medical_specialtyHeptavalent Pneumococcal Conjugate VaccineTime FactorsAdolescentmedicine.medical_treatmentImmunization SecondaryHematopoietic stem cell transplantationPneumococcal conjugate vaccinePneumococcal VaccinesYoung AdultHeptavalent Pneumococcal Conjugate VaccineHumansMedicineChildImmunization Schedulebusiness.industryPneumococcal 7-Valent Conjugate VaccineMiddle AgedAntibodies BacterialPneumococcal polysaccharide vaccineEuropeVaccinationTransplantationInfectious DiseasesImmunizationImmunologyFemalebusinessImmunosuppressive AgentsStem Cell Transplantationmedicine.drugClinical Infectious Diseases
researchProduct

Selective decontamination of the digestive tract in adult-to-adult living related liver transplant patients: a single centre experience

2008

AdultMaleMicrobiology (medical)medicine.medical_specialtyAdolescentSelective decontaminationSettore BIO/19 - Microbiologia GeneraleChemopreventionPostoperative ComplicationsmedicineHumansPharmacology (medical)Intensive care medicineDecontaminationAgedANTIBIOTIC THERAPY SELECTIVE DECONTAMINATION GRAM POSITIVE AND GRAM NEGATIVE BACTERIA TRANSPLANTbusiness.industryBacterial InfectionsGeneral MedicineMiddle AgedAnti-Bacterial AgentsLiver TransplantationGastrointestinal TractSingle centreInfectious DiseasesFemaleTransplant patientDigestive tractbusinessInternational Journal of Antimicrobial Agents
researchProduct

Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry

2009

Patients surviving invasive fungal disease (IFD) and needing further antineoplastic chemotherapy are at high risk of recurrent fungal infection. In the absence of randomised controlled trials in this area, secondary prophylactic regimens are diverse. From 448 patients registered with the Multinational Case Registry of Secondary Antifungal Prophylaxis, we performed an analysis of patients receiving caspofungin (CAS) or itraconazole (ITC). All patients had an underlying haematological malignancy and had been diagnosed with an episode of IFD earlier in their course of treatment. Data collected comprised demographics, underlying disease, first episode of IFD, antifungal prophylaxis, incidence a…

AdultMaleMicrobiology (medical)medicine.medical_specialtyAntifungal AgentsAdolescentItraconazoleAspergillosisChemopreventionEchinocandinsLipopeptidesYoung Adultchemistry.chemical_compoundCaspofunginInternal medicinemedicineHumansAspergillosisPharmacology (medical)RegistriesMycosisAgedFirst episodebusiness.industryIncidence (epidemiology)Stem cell transplantationGeneral MedicineMiddle Agedmedicine.diseaseSurgeryTransplantationTreatment OutcomeInfectious DiseasesMycoseschemistryHematologic NeoplasmsChemoprophylaxisFemaleAntifungal prophylaxisItraconazoleCaspofunginbusinessmedicine.drugInternational Journal of Antimicrobial Agents
researchProduct

Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus

2010

BACKGROUND: This article describes multiple transmissions of rabies via transplanted solid organ from a single infected donor. The empirical Milwaukee treatment regimen was used in the recipients. METHODS: Symptomatic patients were treated by deep sedation (ketamine, midazolam, and phenobarbital), ribavirin, interferon, and active and passive vaccination. Viral loads and antibodies were continuously monitored. RESULTS: Recipients of both cornea and liver transplants developed no symptoms. The recipient of the liver transplant had been vaccinated approximately 20 years before transplantation. Two recipients of kidney and lung transplants developed rabies and died within days of symptomatic d…

AdultMaleMicrobiology (medical)medicine.medical_specialtyRabiesmedicine.medical_treatmentMedizinLiver transplantationAntibodies Viralmedicine.disease_causeAntiviral AgentsOrgan transplantationmedicineHumansHypnotics and SedativesMononegaviralesLyssavirusAgedbiologybusiness.industryRabies virusOrgan TransplantationMiddle AgedViral Loadmedicine.diseasebiology.organism_classificationSurgeryTransplantationTreatment OutcomeInfectious DiseasesRabies VaccinesRabies virusFemaleRabiesbusinessViral load
researchProduct

Mycobacterial Infection: A Difficult and Late Diagnosis in Stem Cell Transplant Recipients

2004

The Infectious Diseases Working Party of the European Blood and Marrow Transplant Group conducted a survey to obtain information about the frequency, presentation, and treatment of mycobacterial infection (MBI) in stem cell transplant (SCT) recipients. Among 29 centers, MBI was diagnosed in 0.79% of 1513 allogeneic and 0.23% of 3012 autologous SCT recipients during 1994-1998 a median of 160 days after transplantation. The mean interval between first symptoms and diagnosis was 29 days and was still longer for patients with atypical MBI or recipients of corticosteroid therapy. The prevalence of MBI was highest among those who received matched unrelated or mismatched STCs from related donors. …

AdultMaleMicrobiology (medical)medicine.medical_specialtyTuberculosisAdolescentmedicine.drug_classmedicine.medical_treatmentHematopoietic stem cell transplantationOpportunistic InfectionsInternal medicineEpidemiologymedicineHumansTuberculosisChildRetrospective StudiesMycobacterium Infectionsbusiness.industryIncidenceHematopoietic Stem Cell TransplantationMiddle Agedmedicine.diseaseSurgeryTransplantationsurgical procedures operativeInfectious Diseasesmedicine.anatomical_structureLate diagnosisChild PreschoolCorticosteroidFemaleBone marrowStem cellbusinessStem Cell TransplantationClinical Infectious Diseases
researchProduct

A comparative study of platelet-rich plasma, hydroxyapatite, demineralized bone matrix and autologous bone to promote bone regeneration after mandibu…

2009

Objectives: 1) to compare mandibular bone regeneration by applying autologous bone, platelet-rich plasma and two biomaterials (synthetic calcium hydroxyapatite, and demineralized bone matrix), and thus establish the potential benefits of these biomaterials in the regeneration of postextraction alveolar bone, 2) to identify wich of them accelerates more bone regeneration and 3) to determine whether there are differences in the postoperative period (pain, swelling, trismus, infection) depending on the material used. Study Design: It consists in a prospective, controlled (with a split- mouth design) and double blinded study. We use as a model an easily reproducible non-critical bone defect: th…

AdultMaleMolarBone RegenerationAdolescentBone MatrixDentistryBiocompatible MaterialsMandibleTrismusYoung AdultDouble-Blind MethodHumansMedicineProspective StudiesBone regenerationGeneral DentistryDental alveolusBone TransplantationPlatelet-Rich Plasmabusiness.industryDemineralized bone matrixRegeneration (biology)Tooth ImpactedMandibleMiddle Aged:CIENCIAS MÉDICAS [UNESCO]DurapatiteOtorhinolaryngologyPlatelet-rich plasmaUNESCO::CIENCIAS MÉDICASTooth ExtractionFemaleMolar ThirdSurgerymedicine.symptombusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.

2013

To validate current donor selection strategies based on previous international studies, we retrospectively analyzed 2646 transplantations performed for hematologic malignancies in 28 German transplant centers. Donors and recipients were high resolution typed for HLA-A, -B, -C, -DRB1, and -DQB1. The highest mortality in overall survival analysis was seen for HLA-A, -B, and DRB1 mismatches. HLA-DQB1 mismatched cases showed a trend toward higher mortality, mostly due to HLA-DQB1 antigen disparities. HLA incompatibilities at >1 locus showed additive detrimental effects. HLA mismatching had no significant effect on relapse incidence and primary graft failure. Graft source had no impact on surviv…

AdultMaleMultivariate analysisAdolescentmedicine.medical_treatmentImmunologyGraft vs Host DiseaseHematopoietic stem cell transplantationHuman leukocyte antigenHLA-C AntigensBiochemistry03 medical and health sciencesYoung Adult0302 clinical medicineimmune system diseasesTransplantation ImmunologyGermanymedicineHLA-DQ beta-ChainsHumansAlleleSurvival rateSurvival analysis030304 developmental biologyAgedRetrospective Studies0303 health sciencesHLA-A AntigensDonor selectionbusiness.industryHistocompatibility TestingHazard ratioHematopoietic Stem Cell TransplantationCell BiologyHematologyMiddle AgedSurvival AnalysisTissue Donors3. Good healthSurvival RateHLA-B AntigensHematologic NeoplasmsHistocompatibilityImmunologyMultivariate AnalysisFemalebusiness030215 immunologyHLA-DRB1 ChainsBlood
researchProduct